Abstract
Translational regulation of the p53 mRNA can determine the ratio between p53 and its N-terminal truncated isoforms and therefore has a significant role in determining p53-regulated signaling pathways. Although its importance in cell fate decisions has been demonstrated repeatedly, little is known about the regulatory mechanisms that determine this ratio. Two internal ribosome entry sites (IRESs) residing within the 5’UTR and the coding sequence of p53 mRNA drive the translation of full-length p53 and Δ40p53 isoform, respectively. Here, we report that DAP5, a translation initiation factor shown to positively regulate the translation of various IRES containing mRNAs, promotes IRES-driven translation of p53 mRNA. Upon DAP5 depletion, p53 and Δ40p53 protein levels were decreased, with a greater effect on the N-terminal truncated isoform. Functional analysis using bicistronic vectors driving the expression of a reporter gene from each of these two IRESs indicated that DAP5 preferentially promotes translation from the second IRES residing in the coding sequence. Furthermore, p53 mRNA expressed from a plasmid carrying this second IRES was selectively shifted to lighter polysomes upon DAP5 knockdown. Consequently, Δ40p53 protein levels and the subsequent transcriptional activation of the 14-3-3σ gene, a known target of Δ40p53, were strongly reduced. In addition, we show here that DAP5 interacts with p53 IRES elements in in vitro and in vivo binding studies, proving for the first time that DAP5 directly binds a target mRNA. Thus, through its ability to regulate IRES-dependent translation of the p53 mRNA, DAP5 may control the ratio between different p53 isoforms encoded by a single mRNA.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Vousden KH, Prives C . Blinded by the light: the growing complexity of p53. Cell 2009; 137: 413–431.
Levine AJ, Oren M . The first 30 years of p53: growing ever more complex. Nat Rev Cancer 2009; 9: 749–758.
Yin Y, Stephen CW, Luciani MG, Fahraeus R . p53 Stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products. Nat Cell Biol 2002; 4: 462–467.
Courtois S, Verhaegh G, North S, Luciani MG, Lassus P, Hibner U et al. DeltaN-p53, a natural isoform of p53 lacking the first transactivation domain, counteracts growth suppression by wild-type p53. Oncogene 2002; 21: 6722–6728.
Marcel V, Dichtel-Danjoy ML, Sagne C, Hafsi H, Ma D, Ortiz-Cuaran S et al. Biological functions of p53 isoforms through evolution: lessons from animal and cellular models. Cell Death Differ 2011; 18: 1815–1824.
Ohki R, Kawase T, Ohta T, Ichikawa H, Taya Y . Dissecting functional roles of p53 N-terminal transactivation domains by microarray expression analysis. Cancer Sci 2007; 98: 189–200.
Powell DJ, Hrstka R, Candeias M, Bourougaa K, Vojtesek B, Fahraeus R . Stress-dependent changes in the properties of p53 complexes by the alternative translation product p53/47. Cell Cycle 2008; 7: 950–959.
Bourougaa K, Naski N, Boularan C, Mlynarczyk C, Candeias MM, Marullo S et al. Endoplasmic reticulum stress induces G2 cell-cycle arrest via mRNA translation of the p53 isoform p53/47. Mol Cell 2010; 38: 78–88.
Candeias MM, Powell DJ, Roubalova E, Apcher S, Bourougaa K, Vojtesek B et al. Expression of p53 and p53/47 are controlled by alternative mechanisms of messenger RNA translation initiation. Oncogene 2006; 25: 6936–6947.
Ray PS, Grover R, Das S . Two internal ribosome entry sites mediate the translation of p53 isoforms. EMBO Rep 2006; 7: 404–410.
Yang DQ, Halaby MJ, Zhang Y . The identification of an internal ribosomal entry site in the 5'-untranslated region of p53 mRNA provides a novel mechanism for the regulation of its translation following DNA damage. Oncogene 2006; 25: 4613–4619.
Levy-Strumpf N, Deiss LP, Berissi H, Kimchi A . DAP-5, a novel homolog of eukaryotic translation initiation factor 4G isolated as a putative modulator of gamma interferon-induced programmed cell death. Mol Cell Biol 1997; 17: 1615–1625.
Imataka H, Olsen HS, Sonenberg N . A new translational regulator with homology to eukaryotic translation initiation factor 4G. EMBO J 1997; 16: 817–825.
Shaughnessy JD, Jenkins NA, Copeland NG . cDNA cloning, expression analysis, and chromosomal localization of a gene with high homology to wheat eIF-(iso)4F and mammalian eIF-4G. Genomics 1997; 39: 192–197.
Yamanaka S, Poksay KS, Arnold KS, Innerarity TL . A novel translational repressor mRNA is edited extensively in livers containing tumors caused by the transgene expression of the apoB mRNA-editing enzyme. Genes Dev 1997; 11: 321–333.
Marash L, Kimchi A . DAP5 and IRES-mediated translation during programmed cell death. Cell Death Differ 2005; 12: 554–562.
Henis-Korenblit S, Shani G, Sines T, Marash L, Shohat G, Kimchi A . The caspase-cleaved DAP5 protein supports internal ribosome entry site-mediated translation of death proteins. Proc Natl Acad Sci USA 2002; 99: 5400–5405.
Lewis SM, Cerquozzi S, Graber TE, Ungureanu NH, Andrews M, Holcik M . The eIF4G homolog DAP5/p97 supports the translation of select mRNAs during endoplasmic reticulum stress. Nucleic Acids Res 2008; 36: 168–178.
Nevins TA, Harder ZM, Korneluk RG, Holcik M . Distinct regulation of internal ribosome entry site-mediated translation following cellular stress is mediated by apoptotic fragments of eIF4G translation initiation factor family members eIF4GI and p97/DAP5/NAT1. J Biol Chem 2003; 278: 3572–3579.
Warnakulasuriyarachchi D, Cerquozzi S, Cheung HH, Holcik M . Translational induction of the inhibitor of apoptosis protein HIAP2 during endoplasmic reticulum stress attenuates cell death and is mediated via an inducible internal ribosome entry site element. J Biol Chem 2004; 279: 17148–17157.
Marash L, Liberman N, Henis-Korenblit S, Sivan G, Reem E, Elroy-Stein O et al. DAP5 promotes cap-independent translation of Bcl-2 and CDK1 to facilitate cell survival during mitosis. Mol Cell 2008; 30: 447–459.
Henis-Korenblit S, Strumpf NL, Goldstaub D, Kimchi A . A novel form of DAP5 protein accumulates in apoptotic cells as a result of caspase cleavage and internal ribosome entry site-mediated translation. Mol Cell Biol 2000; 20: 496–506.
Grover R, Ray PS, Das S . Polypyrimidine tract binding protein regulates IRES-mediated translation of p53 isoforms. Cell Cycle 2008; 7: 2189–2198.
Murray-Zmijewski F, Lane DP, Bourdon JC . p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress. Cell Death Differ 2006; 13: 962–972.
Maier B, Gluba W, Bernier B, Turner T, Mohammad K, Guise T et al. Modulation of mammalian life span by the short isoform of p53. Genes Dev 2004; 18: 306–319.
Cornelis S, Bruynooghe Y, Denecker G, Van Huffel S, Tinton S, Beyaert R . Identification and characterization of a novel cell cycle-regulated internal ribosome entry site. Mol Cell 2000; 5: 597–605.
Herbreteau CH, Weill L, Decimo D, Prevot D, Darlix JL, Sargueil B et al. HIV-2 genomic RNA contains a novel type of IRES located downstream of its initiation codon. Nat Struct Mol Biol 2005; 12: 1001–1007.
Grover R, Sharathchandra A, Ponnuswamy A, Khan D, Das S . Effect of mutations on the p53 IRES RNA structure: Implications for de-regulation of the synthesis of p53 isoforms. RNA Biol 2011; 8: 132–142.
Pudi R, Abhiman S, Srinivasan N, Das S . Hepatitis C virus internal ribosome entry site-mediated translation is stimulated by specific interaction of independent regions of human La autoantigen. J Biol Chem 2003; 278: 12231–12240.
Liberman N, Dym O, Unger T, Albeck S, Peleg Y, Jacobovitch Y et al. The crystal structure of the C-terminal DAP5/p97 domain sheds light on the molecular basis for its processing by caspase cleavage. J Mol Biol 2008; 383: 539–548.
Acknowledgements
We gratefully acknowledge Dr Robin Fahraeus and Dr Jean-Christophe Bourdon for the p53 cDNA constructs, the Israel Structure Proteomic Center (ISPC) at the Weizmann Institute for supplying recombinant DAP5 protein and Sylvia Wilder for technical help. This work was supported by grants from the Flight Attendant Medical Research Institute (to AK and MO), the European Union FP7 APO-SYS (to AK), the Indo French Centre for the Promotion of Advanced Research (to SD), the Department of Biotechnology, India (to SD), and a pre-doctoral fellowship from the Council of Scientific and Industrial Research, India (to DK). AK and MO are incumbents of the Helena Rubinstein Chair of Cancer Research and the Andre Lwoff Chair in Molecular Biology, respectively.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Oncogene website
Supplementary information
Rights and permissions
About this article
Cite this article
Weingarten-Gabbay, S., Khan, D., Liberman, N. et al. The translation initiation factor DAP5 promotes IRES-driven translation of p53 mRNA. Oncogene 33, 611–618 (2014). https://doi.org/10.1038/onc.2012.626
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2012.626
Keywords
This article is cited by
-
It is not all about the alpha: elevated expression of p53β variants is associated with lower probability of survival in a retrospective melanoma cohort
Cancer Cell International (2023)
-
DAP5 enables main ORF translation on mRNAs with structured and uORF-containing 5′ leaders
Nature Communications (2022)
-
MiR-144-3p-mediated dysregulation of EIF4G2 contributes to the development of hepatocellular carcinoma through the ERK pathway
Journal of Experimental & Clinical Cancer Research (2021)
-
Genome-wide CRISPR screen identifies ELP5 as a determinant of gemcitabine sensitivity in gallbladder cancer
Nature Communications (2019)
-
A widespread alternate form of cap-dependent mRNA translation initiation
Nature Communications (2018)